List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 79 studies with search of: "Ciprofloxacin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
Conditions: Otitis Externa;   Otorhinolaryngologic Diseases;   Ear Diseases;   Otitis
Interventions: Drug: 0.3% Ciprofloxacin Ear Drops;   Drug: 0.3% Ciprofloxacin Foam Otic Cipro
2 Recruiting Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Ciprofloxacin (Cipro Inhale, Bay q 3939);   Drug: Placebo
3 Completed Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
Condition: Urinary Tract Infection
Interventions: Drug: Cipro XR (Ciprofloxacin, BAYQ3939);   Drug: Cipro IR (Ciprofloxacin, BAYQ3939)
4 Recruiting Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Ciprofloxacin (PulmoSphere, BAYQ3939);   Drug: Placebo
5 Completed A Phase IV Study of Cipro XR in Uncomplicated UTI
Condition: Urinary Tract Infections
Intervention: Behavioral: Cipro XR (Ciprofloxacin, BAYQ3939)
6 Completed Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens
Condition: Urinary Tract Infections
Intervention: Drug: Cipro XR (Ciprofloxacin, BAYQ3939)
7 Completed Ciprofloxacin on Burned Patients
Conditions: Burns;   Bacterial Infections
Intervention: Drug: Ciprofloxacin (BAYO9867)
8 Completed
Has Results 		Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin
Condition: Healthy
Interventions: Drug: Quinine Sulfate Capsules 324 mg;   Drug: Ciprofloxacin 500 mg
9 Terminated Study of Antibiotics in the Treatment of Colonic Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Metronidazole placebo;   Drug: ciprofloxacin placebo;   Drug: ciprofloxacin;   Drug: metronidazole
10 Not yet recruiting Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis
Condition: Non-Cystic Fibrosis Bronchiectasis
Interventions: Drug: Ciprofloxacin for Inhalation;   Drug: Placebo
11 Terminated Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery
Conditions: Inflammation;   Bacterial Infections
Intervention: Device: slow delivery ciprofloxacin + triamcinolone
12 Recruiting Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Cipro (Ciprofloxacin, BAYQ3939);   Drug: Placebo
13 Completed BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Condition: Bacterial Infections
Interventions: Drug: Ciprofloxacin single dose;   Drug: Ciprofloxacin triple dose
14 Recruiting Cipro Inhaler for Cystic Fibrosis Children Ages 6-12
Condition: Pseudomonas Infection
Intervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)
15 Completed Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg
Condition: Healthy
Interventions: Drug: Ciprofloxacin Extended-Release Tablets 1000 mg;   Drug: Cipro® XR Tablets 1000 mg
16 Completed Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg
Condition: Healthy
Interventions: Drug: Ciprofloxacin Extended-Release Tablets 1000 mg;   Drug: Cipro® XR Tablets 1000 mg
17 Completed Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg
Condition: Healthy
Interventions: Drug: Ciprofloxacin Extended-Release Tablets 500 mg;   Drug: Cipro® XR Tablets (500 mg
18 Completed Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Condition: Urinary Tract Infection
Intervention: Drug: Cipro XR (Ciprofloxacin, BAYQ3939)
19 Not yet recruiting Impact of Formulation on Ciprofloxacin Oral Absorption
Condition: Healthy
Intervention: Drug: ciprofloxacin
20 Recruiting Ciprofloxacin Multiple Dose for Adult Cholera
Condition: Cholera
Interventions: Drug: Ciprofloxacin;   Drug: Azithromycin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services